레스메드(주)
MX ˙ BMV ˙ US7611521078
SecurityMX:RMD / ResMed Inc.
InstitutionFORA Capital, LLC
Latest Disclosed Ownership8,853 shares
Latest Disclosed Value $ 1,987,941
FORA Capital, LLC reports 10.77% decrease in ownership of RMD / ResMed Inc.

On May 14, 2026 - FORA Capital, LLC filed a 13F-HR form disclosing ownership of 8,853 shares of ResMed Inc. (MX:RMD) valued at $1,987,941 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 9,922 shares of ResMed Inc.. This represents a change in shares of -10.77% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F RESMED COM 761152107 8,853 -1,069 -10.77 1,988 -16.83 0.1457
2026-02-13 2025-12-31 13F RESMED COM 761152107 9,922 9,067 1,060.47 2,390 920.94 0.2890
2025-11-13 2025-09-30 13F RESMED COM 761152107 855 -15,156 -94.66 234 -94.33 0.0414
2025-08-13 2025-06-30 13F RESMED COM 761152107 16,011 16,011 4,131 0.4587
2024-02-14 2023-12-31 13F RESMED ORD COM 761152107 0 -25,057 -100.00 0 -100.00
2023-11-13 2023-09-30 13F RESMED ORD COM 761152107 25,057 21,172 544.97 3,705 336.91 0.3252
2023-08-11 2023-06-30 13F RESMED INC. CMN COM 761152107 3,885 -5,093 -56.73 849 -56.87 0.1205
2023-05-12 2023-03-31 13F RESMED INC. CMN COM 761152107 8,978 914 11.33 1,966 17.16 0.1969
2023-02-08 2022-12-31 13F RESMED COM 761152107 8,064 5,967 284.55 1,678 0.2709
2022-11-14 2022-09-30 13F RESMED INC. CMN COM 761152107 2,097 2,097 0 0.0879
2022-05-12 2022-03-31 13F RESMED INC. CMN COM 761152107 0 -2,698 -100.00 0 0.0000
2022-02-11 2021-12-31 13F RESMED INC. CMN COM 761152107 2,698 -5,386 -66.63 1 -100.00 0.2728
2021-11-15 2021-09-30 13F RESMED INC. CMN COM 761152107 8,084 8,084 2 0.5379
2021-02-12 2020-12-31 13F RESMED INC. CMN COM 761152107 0 -2,055 -100.00 0 -100.00
2020-11-13 2020-09-30 13F RESMED INC. CMN COM 761152107 2,055 2,055 352 0.2308
2020-05-15 2020-03-31 13F RESMED INC CMN COM 761152107 0 -1,631 -100.00 0 -100.00
2020-02-14 2019-12-31 13F RESMED INC CMN COM 761152107 1,631 1,631 253 0.0255
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.